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Summary
The processes that govern the generation ofpathogenic anti-DNA autoantibodies in human systemic
lupus erythematosus (SLE) are largely unknown . Autoantibodies may arise as a consequence of
polyclonal B cell activation and/or antigen-driven B cell activation and selection . The role
of these processes in humoral autoimmunity may be studied by molecular genetic analysis of
immunoglobulin (Ig) variable (V) regions of antibodies that are characteristic ofSLE. We have
analyzed the gene elements that encode a high affinity, IgG anti-double-strandedDNA autoantibody
secreted by a monoclonal Epstein-Barr virus (EBV)-transformed cell line derived from a patient
with active SLE . In addition, we have identified, cloned, and sequenced the germline counterparts
of the VH and VL genes expressed in this autoantibody . The comparison of both sets of gene
elements shows that the autoantibody VH and VL regions harbor numerous somatic mutations
characteristic of an antigen-driven immune response. The light chain expressed in this autoantibody
is a somatically mutated variant of the kv325 germline gene that is frequently associated with
paraproteins having autoantibody activity and with Ig molecules produced by malignantB cells
that express the CD5 antigen . Furthermore, the utilized DH segment has been repeatedly found
in multireactive, low affinity IgM anti-DNA autoantibodies from SLE patients and healthy
individuals . These results suggest that pathogenic IgG anti-DNA autoantibodies in human SLE
may arise through antigen-driven selection of somatic mutations in the gene elements that frequently
encode multireactive IgM autoantibodies.
Systemic lupus erythematosus is an autoimmune disease
characterized by the production of antibodies that react
with a variety of ubiquitous autoantigens including ribonu-
cleoproteins, cytoskeleton proteins, and nucleic acids, such
as single-stranded (ss)t and double-stranded (ds) DNA (re-
viewed in reference 1) . A direct role for IgG anti-DNA anti-
bodies in pathogenesis has been established by the correla-
tion of serum antibody levels with disease activity (2) and
the demonstration of DNA/anti-DNA immune complex-
depositions at sites of tissue damage (3) . Although human
anti-DNA antibodies have been extensively characterized by
immunochemical, idiotypic, and structural analyses, (e.g., 4-7)
the processes that lead to the production of these autoanti-
'Abbreviations used in this paper: ds, double stranded; ss, single stranded .
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bodies in SLE are largely unknown . Two, not mutually ex-
clusive models have been proposed to explain their origin .
The first model suggests that anti-DNA autoantibodies merely
arise through antigen independent, polyclonal B cell activa-
tion (8, 9) . This model denies a role for antigen in the au-
toantibody response and predicts the generation of a mul-
ticlonal population ofB cells with unmutated or randomly
mutated IgV regions. The second model proposes a role for
(auto)antigen in the induction and maintenance ofautoanti-
body production . This scenario predicts the generation of
an oligoclonal population ofB cells that express V regions
with nonrandom patterns of somatic mutations . These pat-
terns are presumably the result ofpositive selection ofreplace-
ment mutations in parts of the V region that are in contact
with antigen which leads to higher antibody affinity (10-12) .
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code disease-associated anti-DNA autoantibodies will con-
tribute to our understanding of the mechanisms involved in
humoral autoimmune disease.
Recently, several groups have reported on the analysis of
V genes expressed in human IgM anti-DNA autoantibodies
derived from both patients and healthy individuals (13-18) .
Typically, these are low affinity, often broadly crossreactive
antibodies that are encoded by strongly conserved, germline
V regions . Whether these naturally occurring antibodies can
give rise to high affinity, monospecific IgG anti-DNA au-
toantibodies characteristically present in the sera of patients
with SLE is unknown .
Here, we present the binding characteristics, idiotype ex-
pression, and complete nucleotide sequences ofthe expressed
VH and VL genes ofa high affinity, monoreactive IgG anti-
DNA autoantibody secreted by anEBVtransformed cell line
derived from a patient with active SLE . In addition, we present
the nucleotide sequences of the patients' germline counter-
parts of these expressed VH and VL genes . Comparison of
these sequences suggests that this IgG anti-DNA autoanti-
body-secreting B cell clone arose as a consequence of antigen-
dependent stimulation and selection through its Ig receptor.
The gene elements that encode this Ig receptor are frequently
associated with IgM autoantibodies present in patients and
healthy individuals.
Materials and Methods
Generation of Monoclonal IgG-Secreting EBV-TransformedB Cell
Lines. Peripheral blood mononuclear cells from a patient with ac-
tive SLE (Tou) were isolated and depleted ofT cells using SRBC
as described elsewhere (19) . To increase the proportion of IgG-
secreting cell lines, non-T cells were depleted of surface-IgM ` B
cells by rosetting with anti-human IgM-coated ox red blood cells
as described (20) . The sIgM-depleted nonT cells were incubated
with the EBV-containing supernatant of the marmoset B95.8 cell
line and cultured in 96-well plates under limiting dilution condi-
tions (21) . After 3-4 wk, clones from 96-well plates containing
<25% growth were assayed for Ig secretion and expanded .
Assayfor Ig Isotype .
￿
The isotype of secreted Ig was determined
in direct binding ELISA using affinity-purified goat anti-human
A, y, a, and K-X specific antisera (Tago Inc ., Burlingame, CA) as
described (16) .
Assayfor Antigen Binding Properties and Id Expression .
￿
Culture
supernatants were assayed for anti-ssDNA and anti-dsDNA activity
using a fluid phase binding assay (22) . Preparation of photobi-
otinylatedDNA and assay conditions wereexactly as described (22)
with one modification: microtiter plates were coated with 5 Wg/ml
goat anti-human IgG antibody (Tago Inc.) rather than goat
anti-mouse K antibody. Anti-dsDNAbinding activity was also tested
in an immunofluorescence assay employing Chritidia lucilliae hemo-
flagellates as a substrate (23) . Culture supernatants with anti-DNA
binding activity were further analyzed for binding activity against
a panel of 13 antigens using direct binding solid phase ELISA . The
panel of antigens consisted of bovine heart cardiolipin, BSA,
dinitrophenol-BSA, trinitrophenol-BSA, arsonate-BSA, fluoresceine-
BSA, rabbit IgG, human insulin, human thyroglobulin, hen egg
lysozyme, tetanus toxoid, cytochrome C, and rabies virus. Con-
trols, coating, and assay conditions were as described elsewhere (16) .
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IgG anti-DNA antibodies were assayed for L chain-associated Id
expression in an ELISA system using the 17.109 and JG-B1 mAb
(24, 25).
DNA andRNA Isolation .
￿
Total RNA was isolated from the
EBV-transformed cell lines using RNAzol- according to the man-
ufacturers protocol-(Cinna/Biotecx, Friendswood, TX) . Genomic
DNA was isolated from 3.10 5 T cells, granulocytes, and EBV-
transformed B cells as described (26) .
First StrandcDNA Synthesis andPCR.
￿
For first strand cDNA
synthesis, 9 Ag of total RNA was annealed to 100 ng of a Cy or
Cu-specific primer (TL 50 and TL 51, Table 1) and extended with
AMV reverse transcriptase (Pharmacia, Uppsala, Sweden) using stan-
dard procedures (27) . For PCR amplification, 1/10 of the cDNA
first strand reaction mixture or 50 ng of the isolated genomicDNA
was supplementedwith 500 ng ofthe appropriate 3' and 5' primers
and amplified in a 100 141 reaction mixture using 3 U Taq DNA
polymerise according to the manufacturers protocol (Promega Bio-
tec, Madison, WI) . The 5' primers used for these experiments (Table
1) were designed to anneal to the leader sequences of members of
the human VH (TL 6, 15, 46, 47, 48) or VK (TL 40, 41, 43, 52)
gene families based on published sequences (EMBL database, re-
lease 23) . The 3' end primers were the Cy and Cu primers used
incDNA first strand synthesis or, for genomicDNA, primers that
hybridize to 3' end genomic flanking regions oftheVH4 or VKIIIb
genes (based on 27-29) . To facilitate subdoning, all primers con-
tained an attached or internal restriction site (Table 1) . PCR
amplifications were carried out in a Bioexcellence Thermal Cycler
and consisted of 35 cycles of 1.5 min ofdenaturation at 94°C, 1 .5
min ofprimer annealing at 55°C, and 3 min ofextension at 72°C .
Finally, after 35 cycles, reaction mixtures were incubated at 72°C
for 10 min to ensure full extension ofallPCRproducts . First strand
cDNA andPCR reactions were set up in duplicate in order to min-
imize errors introduced by AMV reverse transcriptase and/or Taq
polymerase.
Cloning and Sequencing ofPCR-Amplified Material.
￿
PCR am-
plified material was separated on a 1% low melting point agarose
gel containing 1 wg/ml ethidium bromide . A band of 400-450 by
was excised, purified, cut with the appropriate restriction enzymes,
and ligated onto Bluescript vector (Stratagene, LaJolla, CA) using
standard procedures (27) . After transformation o£competent DH5a
cells, colonies were transferred to nitrocellulose and screened with
[32P)labeled VH or VK-specific probes (28, 29) . Dideoxy se-
quencing was carried out using double strandedDNA and the T7
sequencing kit (Pharmacia) . All inserts were sequenced from two
directions and from multiple independent clones .
Results
Generation ofAn IgGAnti-DNA Secreting EBV-Transformed
Cell Line. Monoclonal cell lines were generated by EBV
transformation of sIgM-depleted non-T cells of SLE patient
Tou under limiting dilution conditions. Supernatants oftrans-
formed cell lines were screened for the isotype of the secreted
Ig in an ELISA . Subsequently, anti-DNA binding properties
of IgG-producing cell lines were determined in a fluid phase
assay using photobiotinylated ssDNA and dsDNA . The su-
pernatant of one cell line (T14) out of 72 IgG-secreting cell
lines tested displayed anti-ssDNA and anti-dsDNA binding
activity (Fig . 1) . Binding of T14 supernatant to dsDNAwas
confirmed in an immunofluorescent assay employing the
hemoflagellate C. lucilliae, which detects high affinity autoan-
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Figure 1 .
￿
Serial dilutions of supernatant from cell line T14 were tested
in a liquid phase binding ELISA for reactivity with ssDNA and dsDNA
(see Materials and Methods) ; (") binding to ssDNA, (*) binding to
dsDNA. Background binding activity ofthe preformed anti-DNA/dsDNA
(0), and anti-DNAAsDNA (A) complexes was determined on plates that
had not been coated with goat anti-human IgG antibodies .
tibodies to dsDNA only (reference 23, not shown) . To assess
the degree of crossreactivity with other antigens, superna-
tant from T14 was tested against a panel of 13 antigens in
direct binding ELSIA (see Materials and Methods) . No binding
to any of the antigens tested was observed (results not shown).
Cloning and Sequencing of the Expressed V Regions.
￿
For
cloning of the expressed VH and VL regions of T14, total
cellular RNA was annealed to CT- or CK-specific primers
and extended withAMV reverse transcriptase. Subsequently,
first strand cDNA was amplified in the PCR reaction using
combinations of the CT or Cic primer and primers specific
for the leader sequences of several human VH or VK gene
families respectively (Table 1) . For both H and L chain, a
single primer combination (Cy and VH4 for the H chain
and Crc and VKIII for the L chain) resulted in the generation
of PCR-amplified material of the expected size. The expres-
sion in T14 of genes belonging to the VH4 and VKIII gene
families was confirmed in a Northern blotting experiment
using the different VH and VK gene family-specific probes
(not shown). The PCR-amplified material was cloned into
Bluescript and multiple colonies containing the correct in-
sert as detected by colony hybridization with VH4 and VKIII-
specific probes were selected for dideoxy sequencing .
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The nucleotide sequences of the VH ,and VL regions of
T14 (VH4T14 and VKIIIb.T14 respectively) are shown in
Figs. 2 and 3 . Comparison of these sequences with sequences
in the EMBL data-bank revealed that VH4X14 is most ho-
mologous (95.8%) to the VH4.21 germline gene (Fig. 2 ;
reference 30) . Other germline VH4 genes displayed 91.1%
or less sequence homology to VH4T14 (Table 2; references
30, 31). TheL chain expressed in T14 displays most homology
to the kv325 germline gene segment (98.6%), a member of
the VKIIIb subfamily (reference 32; Fig. 3) . Other VKIII
sequences displayed 96.7% or less sequence homology to
VKIIIbX14 (Table 2 ; reference 33) .
The nucleotide sequence of a stretch of 90 nucleotides at
the 5' end of the y C region gene included in our PCR-
amplified material revealed that autoantibody T14 is of the
IgG3 subclass.
Cloning and Sequencing ofGermline V Genes.
￿
We wished
to determine if the V genes expressed in T14 indeed derived
from the published germline VH4.21 and VKIIIb elements
as suggested by the comparison with sequences in the EMBL
databank . Such an analysis is necessary to determine whether
nucleotide differences between expressed and published germ-
lineV genes do represent somatic mutations or, alternatively,
reflect allelic heterogeneity or the existence ofas yet unknown
V gene elements . To that end, we used two approaches. First,
we used the PCR to determine whether the `mutated' VH4
CDR1 sequence ofcell line T14 existed in the germlineDNA
of patient Tou (14) . PCR reactions used a common 3' end
primer that hybridized to framework 3 sequences of VH4
genes (TL90) and either a 5' end primer specific for CDR1
of the germline VH4 gene (TL91) or a 5' primer specific for
+1
CAG GTG CAG CTA CAG CAG TGG GGC GCA GGA CTG TTG AAG Tou-VH4.21
CCT TCG GAG ACC CTG TCC CTC ACC TGC GCT GTC TAT GGT Tou-VH4.21
CDRI
GGG TCC TTC AGT GGT TAC TAC TGG AGC TGG ATC CGC CAG Tou-VH4 .21
--- --- --- --- --- C-1 . -T- --- --- --- --T --- --- VH4-T14
k * k
CCC CCA GGG AAG GGG CTG GAG TGG ATT GGG GAA ATC ATT Tou-VH4 .21
--- --- --- --- --- --- --- --- --- -..- --.T --- --- VH4-T14
k
CDR2
CAT AGT GGA AGC ACC AAC TAC AAC CCG TCC CTC AAG AGT Tou-VH4 .21
CGA GTC ACC ATA TCA GTA GAC ACG TCC AAG AAC CAG TTC Tou-VH4.21
TCC CTG AAG CTG AGC TCT GTG ACC GCC GCG GAC ACG GCT Tou-VH4.21
--- --- --- 7.-- --G, --- -C- --- --- --- --- --- --- VH4-T14
* k
GTG TAT TAC TGT GCG AGA
￿
Tou-VH4.21
--T --- --- --- --- ---
￿
VH4-T14
Figure 2.
￿
Comparison of nucleotide sequences of the germline Tou-
VH4.21 gene and the VH4T14 gene expressed in cell line T14. Stripes
indicate nucleotide identity . (*) replacement mutation .A : single nucleo-
tide difference with the publishedVH4.21 sequence (reference 31) . CDR:
complementarity determining region . These sequence data are available
from EMBL/GenBank/DDBL under accession numbers X56591 and
X56592 .Table 1.
￿
Nucleotide Sequences of Primers Used in First Strand cDNA and PCR Reactions
Primer no .
￿
Specificity
cDNA synthesis primers
TL50
￿
Cgamma
TL50
￿
Ckappa
PCR primers
TL46
￿
VH1 leader
TL47
￿
VH3 leader
TL48
￿
VH4 leader
TL15
￿
VH5 leader
TL 6
￿
VH6 leader
TL40
￿
VK1 leader
TL41
￿
VK2 leader
TL52
￿
VK3 leader
TL43
￿
VK4 leader
TL65
￿
VH4 3' flank
TL75
￿
kv325
TL91
￿
VH4.21 CDR1
TL92
￿
VH4.T14 CDR1
TL90
￿
VH4.FR3
Sequences of oligonucleotide primers used for first strand cDNA synthesis and PCR amplification of V genes . Capital letters refer to variable or
constant region sequences . Restriction sites are underlined .
the CDR1 of the `mutated'VH4 gene (TL 92). `Germline'
primer TL91 will also amplify the closely related V58 gene
(31) and possibly additional, not as yet identified, VH4 genes
with identicalCDR1 regions . The PCR reaction was per-
GAT ACC ACC GGA GAA ATT GTG TTG ACG CAG TCT CCA GGC Tou-kv325
CCC TGT CTT TGT CTC CCA GGG GAA AGA GCC ACC CTC TCC Tou-kv325
CDR1
TGC AGG GCC AGT CAG AGT GTT AGC AGC ACC TAC TTA GCC Tou-kv325
ATC TAT GGT GCA TCC AGC AGG GCC ACT GGC ATC CCA GAC
-- --- --- --- --- --- --- --- --- --- --- --- ---
CDR3
TAC TGT CAG CAG TAT GGT AGC TCA CC
TGG TAC CAG CAG AAA CCT GGC CAG GCT CCC AGG CTC CTC
--- --- --- --- --r, --- -C- --- --- --- --- --- ---
CDR2
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Tou-kv325
VKIIIb-T14
Tou-kv325
VKIIIb-T14
AGG TTC AGT GGC AGT GGG TCT GGG ACA GAC TTC ACT CTC Tou-kv325
ACC ATC AGC AGA CTG GAG CCT GAA GAT TTT GCA GTG TAT Tou-kv325
Tou-kv325
VKIIIb-T14
Figure 3 .
￿
Comparison of the nucleotide sequence of the germline Tou-
kv325 gene segment and the VKIIIb gene segment expressed in theIgG
anti-DNA autoantibody T14 . TheTou-kv325 gene segmentis 100% iden-
tical to the previously published kv325 consensus sequence (33) . For ex-
planation see legend to Fig. 2 . These sequence data are available from
EMBL/GenBank/DDBJ under accession numbers X56593 and X56594 .
Sequence (5'-3')
ggaattcCAGGCAGCCCAGGGCCGCTGTGC
ggga~AACAGAGGCAGTTCCAGACTT
gg ag attcATGGACTGGACCTGGAGG
gg ag attcGAGTTTGGGCTGAGCTGG
gg ag attcCTGGTGGCAGCTCCCAGA
ACCG ag attcTCGCCCTCCTCCTG
TGTaa cttCCTCATCTTCCT
ggggatccATGGACATGAGGGTCCCC
ggggatccATGAGGCTCCCTGCTCAG
ggggatccATGGAAACCCCAGCGCA
ggggatccATGGTGTTGCAGACCCAG
gg tg cgacGGGCTCACACTCACCTCCCCT
gg t g cgacTAAACAATGAAGGTCTTGCA
TGGTGGGTCCTTCAGTGGTTACTA
TGGTGGGTCCTTCAGTGGTCATTT
ACAGTAATAAACAGCCGTGTCCGC
Table 2.
￿
Comparison of VH4-T14 and VKIIIb-T14 with
Published Germline VH4 and VKIII Genes
Molecular Characterization of a Human IgG Anti-DNA Autoantibody
Percentage of nucleotide identity between the VH4 and VKlllb genes
expressed in T14 and germline VH4 and VKlllb sequences .
" Germline VH4 sequences from references 30 and 31 .
t Germline VKlllb sequences from reference 33 .
$ Germline VH4 and VKlllb sequences from patient Tou .
Gene
Percent sequence
identity with
VH4-T14 Gene
Percent sequence
identity with
VKIIIb-T14
VH4.21" 94.8 kv325# 98 .6
V71-4 89.0 kv305 96 .7
V11 87.1 kv3g 93 .0
V12G-1 85.7 kv3g" 92.3
V58 91.1 kv3h 91 .3
V2-1 86.5
V79 87.4
V71-2 87.9
2-911 86.7
Tou17s 85.9
Tou10§ 87.6
Tou-VH4.21$ 95.1 Tou-kv325s 98.6Table 3.
￿
Pattern and Extent ofSomatic Mutations in the
￿
formed using three sources ofgenomicDNA : (a)DNA from
V Regions of Cell Line T14
￿
cell line T14, (b)DNA from peripheral blood T cells from
patientTou and as a control, (c)DNA from the granulocytes
CDR regions
￿
FR regions
￿
of a healthy, unrelated person. In all experiments, the iden-
tity of fragments generated in the PCR was confirmed in
a Southern blotting experiment using a [
3
P]-labeled V114
specific probe. The results of these experiments are shown
VH
￿
2
￿
4 Tyr- His
￿
5
￿
2 Ser - Arg
￿
in Fig. 4 . A combination of the germline CDR1 primer (TL
Tyr -" Phe
￿
Val - Ala
￿
90) and TL91 generated a VH4-hybridizing band of the ex-
Glu - Asp
￿
pected size (205 bp) in all three DNA samples, indicating
Asn -" Ser
￿
the presence ofVH4 genes (such as VH4.21 and V58) con-
taining thisCDR1 region . In contrast, a combination of the
VL
￿
0
￿
3 Ser - Asn
￿
1
￿
1 Gly- Ala
￿
`mutated' CDR1 primer (TL92) andTL 91 generated aVH4-
Ser - Arg
￿
hybridizing band in the DNA sample from cell line T14 only.
Ser - Thr
￿
Together, these data demonstrate that the mutated CDR1
sequence exists in the rearrangedDNA of the T14 cell line
but not in T cells from the same donor or in granulocytes
The three-letter amino acid code is used . CDR, complementarity deter-
￿
from a control donor. Therefore the nucleotide sequence sub-
mining region . FR, framework region .
￿
stitutions in the CDR1 region of cell line T14 result from
a
ß'
b
e'
TL9
~4»
TL92
TL91
COR-1
TL92
TL9o
Figure 4.
￿
PCR analysis ofsomaticmutations in the
expressed VH4 gene in cell line T14 . (a) Diagramatic
representation of the prototypic germline VH4 gene
(VH4.21) and the expressedVH4 gene segment (T14)
_ em -
￿
with locations and directions ofPCR primers TL91,
-w -
￿
TL92 (5' end primers), and TL90 (3' end primer) . (b)
-w -
￿
Ethidium bromide-stained gel showing amplifiedprod-
ucts. (c) Southern blots showing specific amplified
_w _
￿
products after probing with 132Pl-labeled VH4 probe .
- Ws -
￿
Genomic DNA was isolated from the cell line T14,
from T cells of patient Tou, and from granulocytes
from a control donor. Lanes 1, 5, and 9, genomic
_
￿
_
￿
DNA from T cell ofpatient Tou ; lane 2, 6, and 10,
DNA from cell line T14; lane3, 7, and 11, DNA from
granulocytes of a control donor; lane 4, 8, and 12,
- m° -
￿
negative controls (no DNA added) ; lane 1-4, primers
TL91 and TL90 ; lane S-8, primers TL92 and TL90 ;
2
￿
3
￿
4
￿
5
￿
6
￿
7
￿
a
￿
9
￿
1
￿
2
￿
3
￿
4
￿
5
￿
6
￿
7
￿
a
￿
9
￿
lane 9-12, primers TL65 and TL48 .
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￿
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QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQPPGKGLEWIGEII Tou-VH4 .21
-------------------------------HF----------------D--
￿
VH4-T14
CDR-2
HSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCAR Tou-VH4 .21
-------S----------------------R-p,------------
￿
VH4-T14
CDR- I
DTTGEIVLTQSPGPCLCLPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLL Tou-kv325
---------------------------------T-R---------A------
￿
VKIIIb-T14
IYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSS Tou-kv325
---------------------------------------------N- VKIIIb-T14
Figure 5 .
￿
Comparison of the deduced amino acid sequences ofthe germ-
line and expressedVH genes (A, TouVH4.21 and VH4T14) and the germ-
line and expressed VL genes (B, Tou-kv325 and VKIIIbT14) of cell line
T14 . The homologous germline VH andVL genes are derived from pa-
tient Tou's own germline DNA . Single-letter amino acid code is used.
Dashes indicate identity with the germline sequence.
somatic mutations . The same approach was used to establish
the absence of the mutated VKIIIb CDR1 sequence in the
germline DNA of patient Tou . Again these experiments
demonstrated the absence of this mutated sequence in the
germline of the SLE patient Tou (not shown) .
In the second approach, we cloned and sequenced 25 VH4
genes from the genomicDNA of patient Tou's T cells using
a combination of a 5' VH4 leader sequence-specific primer
(TL48) and a 3' end VH4 flanking region primer (TL 65) .
The results of these experiments demonstrated that the germ-
line of patient Tou indeed contains a gene segment that differs
by only one nucleotide from the sequence of the published
VH4.21 gene segment . The one nucleotide difference was
also present in the expressed VH4 gene in cell line T14, ren-
dering it highly likely that the expressed VH4 gene was de-
rived from this allele. Furthermore, none ofthe other 24VH4
genes, including twonew members of the VH4 gene family,
displayed a higher degree of homology with the sequence
of the mutated VH4 gene thanVH4.21 (results summarized
in Table 2) . Similarly, we designed two primers hybridizing
to the 3' and 5' sequences flanking the kv325 coding region
(TL75 and TL52, Table 1; reference 29) to examine whether
the nucleotide differences between the expressed VKIIIb gene
segment in T14 and the published kv325 nucleotide sequence
reflect true somatic mutations or a polymorphism of thisVK
gene segment . PCR-amplified material from genomicDNA
extracted from the T cells of patient Tou was cloned into
Bluescript and several independent VKIII-hybridizing colo-
nies were selected for sequencing. The results of these ex-
periments showed that the germline of patient Tou harbors
466
GGA TGG CCG TAT TAC TAT GGT GCG GGG AGT TAT TAT AAG CGT GGC .PH-T14
- --- --- --- --- T-- --- --- --- --- ---
￿
DXP11
TAC TTT GAC TAC TGG GGC CAG GGA ATC CGG GTC ACC GTC TCC TCA JH-T14
TGG ACG TTC CCC CAA GGG ACC AAG GTG GAA ATC AAA CCA
￿
JK-T14
--- --- --- --- --- --- --- --- --- --- --- --- --- JK1
Figure 6 .
￿
Alignments of nucleotide sequences ofDH, JH, andJK ele-
ments expressed in cell line T14 and published germline elements (refer-
ences 35 and 36) . See legend to Fig . 2 . The sequence data are available
from EMBL/Genband/DDBJ under accession numbers X56592 and
X56594 .
a VKIIIb gene segment that shares 100% sequence homology
with the published kv325 gene (Fig . 3) . In line with these
results, we found thatT14 did not react with the antiVKIIIb
mAb 17.109 but did react with the antiVKIIIbmAb JG-B1 .
The latter mAb is less affected by changes in the structure
ofthe VKIIIBL chain as a result ofsomatic mutations (Carson,
D., personal communication) .
Pattern and Extent of Somatic Mutations in the VH and VL
Region . As shown in Figs . 2 and 3, the VH4 and VKIIIb
genes expressed in cell line T14 differ from their respective
germline counterpart by 14 and 5 nucleotides, respectively .
Comparison of deduced amino acid sequences of the expressed
VH4 and VKIIIb genes with their respective germline coun-
terparts shows that nucleotide differences result in both si-
lent and replacement mutations (Fig. 5) . In Table 3 we have
summarized the nature of these mutations (silent or replace-
ment) and the distribution overFR and CDR regions . Seven
out of ten replacement mutations but onlytwo out of eight
silent mutations reside in the combined VH and VLCDR
regions . This pattern is completely reversed in the combined
VH and VL FR regions : only three out of ten replacement
and six out of eight silent mutations reside in the framework
regions . Such a non-random distribution of silent and replace-
ment mutations in antibody V regions is consistent with a
process of Ig receptor-dependent stimulation and selection
ofmutations (12) . The only two replacement mutations not
found in the CDR of theVH region are localized in the 67-85
region of FR3 . This region is highly conserved across the
different VH families ofdifferent species and perhaps involved
in antigen binding (34) . Strikingly, four of the ten replace-
ment mutations yield an arginine or asparagine codon . These
residues are involved in promoting and/or stabilizing DNA-
protein interactions and arginine residues have been frequently
found in the mutated CDR regions of murine anti-DNA
autoantibodies (22) .
DH, JH, andJK Gene Usage
￿
The diversity segment in
VH4T14 displays 1 nucleotide difference with the germline
DXP'1 gene segment (35) and is flanked by eight and six
nucleotides on the 5' and 3' end, respectively (Fig. 6) . These
flanking sequences may representN region insertions. The
nucleotide difference yields an alanine codon . The JH ele-
ment inVH4T14 differs by three nucleotides from the germ-
lineJH4 gene (Fig . 6; reference 36) . One of these differences
yields an arginine codon . TheJK element in T14VKIIIb is
identical to the germline JK1 element (Fig. 6) .
Molecular Characterization of a Human IgG Anti-DNA AutoantibodyDiscussion
Much research in the field of autoimmunity is directed to-
wards the identification of the processes that contribute to
the generation ofpathogenic autoantibodies. Polyclonal B cell
activation, antigen-driven B cell activation and selection, or
both, may play a role in humoral autoimmunity (11, 12, 22,
37) . These processes are inprinted in the Ig receptor mole-
cules of theB cells that partake in these responses: polyclonally-
activated B cells express germline V regions with no or a
few randomly distributed somatic mutations whereas antigen-
stimulated and selectedB cells expressV regions which harbor
nonrandom distributions of somatic mutations (reviewed in
reference 38) . Thus, the molecular genetic analysis of the V
regions of pathogenic autoantibodies may contribute to our
understanding ofhumoral autoimmunity. Indeed, analysis of
theV regions ofautoantibodies secreted by hybridomas from
MRL/Ipr mice, has proven pivotal in understanding the patho-
genesis of humoral autoimmunity in this animal model for
human SLE (11, 12) . These studies in the MRL/lpr mouse
strongly suggest that anti-DNA autoantibodies arise as a con-
sequence of an antigen-driven, oligoclonal B cell activation
and expansion as manifested by the occurrence of nonran-
domly distributed somatic mutations in the V regions of
clonally-related IgG anti-DNA autoantibody-secreting hybrid-
omas . Though serologically and pathologically similar to
human SLE, theMRL/1pr mouse displays additional immuno-
logical abnormalities not normally associated with human
SLE. Therefore, understanding the processes that lead to the
generation ofpathogenic autoantibodies in humans requires
the analysis of the V regions ofhuman B lineage cells that
secrete IgG autoantibodies . Therefore, we investigated the
binding characteristics, idiotype expression, and complete
nucleotide sequences of the expressed VH andVL genes and
their germline counterparts of an IgG anti-DNA autoanti-
body derived from a patient with active SLE .
Antigen Binding Properties ofthe IgG Anti-DNA Autoanti-
body. Several properties of the T14 autoantibody distinguish
it from previously described human monoclonal autoanti-
bodies. T14 is a high affinity IgG anti-dsDNA autoantibody
characteristic of serum and immune-complexed anti-DNA
antibodies of patients withSLE . Moreover, T14 is of the IgG3
subclass and therefore able to fix complement . High affinity,
complement fixing anti-DNA antibodies are thought to par-
ticipate in the pathogenesis of glomerulo-nephritis in SLE
patients and in a number of animal models for SLE (39-41) .
Unlike many IgM anti-DNA autoantibodies analyzed thus
far (13-18), T14 does not belong to the class of multireactive
antibodies as manifested by the lack ofreactivity with a panel
of 13 antigens. Together these properties of the T14 mAb
render it highly likely that this antibody is involved in the
disease process in this SLE patient .
VH, DH, andJH Utilization .
￿
The VH region expressed
in cell line T14 is the rearrangement product of a member
of the VH4 gene family, the DXP'1 gene segment and the
JH4 gene segment . Nucleotide sequence comparison with
published VH4 genes suggested the use ofa somatically mu-
tated form ofthe VH4.21 germline gene . Alternatively, such
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nucleotide differences could stem from novel members and/or
from polymorphisms ofknown members of the VH4 gene
family. In order to discriminate between these alternatives,
we obtained sequence data from 25 VH4 genes cloned from
the patient's genomic DNA . Indeed, these data showed
that the patient's VH4.21 gene displayed most homology with
the expressed and mutated VH4T14 gene. In this regard,
a single base pair mismatch between patient Tou's expressed
and germlineVH.21 germline gene on the one hand and the
publishedVH4.21 germline gene on the other hand was par-
ticularly informative. This strongly suggested that VH4X14
was the mutated descendant of this allele, which was further
supported by the finding that the patients germline DNA
lacked the mutatedCDR1 sequence present in VH4T14. To-
gether, these findings strongly suggest that the nucleotide
substitutions in the VH regions that encode the T14 anti-
DNA antibody result from somatic mutations.
A portion of the antigen-binding site of antibody mole-
cules is encoded by the region that encompasses the DH ele-
ment (CDR3) . Recently, Cairns et al . (13) noted the fre-
quent utilization ofthe germlineDXP'1 gene element in IgM
anti-DNA autoantibodies from both patients and healthy in-
dividuals . In concordance with these results, we found ex-
pression of the DXP'1 gene in the T14 I,gG anti-DNA au-
toantibody. In each case DXP'1 is used in the same reading
frame which yields a total of 5 Tyrosine residues in this por-
tion of the CDR3 region. Computer modeling has shown
that the antibody combining site ofIgG anti-DNA antibodies
from NZB/NZW mice, an animal model for SLE, is domi-
nated by arginine and tyrosine side chains that may contribute
toDNA binding through electrostatic interactions (7) . Simi-
larly, a high tyrosine content of the CDR3 region of both
natural and pathogenic human anti-DNA antibodies could
be important in determiningDNA binding activity. Moreover,
these findings show a surprising degree of uniformity in the
CDR3 region of some natural anti-DNA autoantibodies and
the pathogenic anti-DNA autoantibody T14, suggesting a
possible relationship between these two types ofanti-DNA
autoantibodies :
VL andJK Usage .
￿
The L chain expressed in cell line T14
is a somatically mutated form of the kv325 germline gene,
a member of the VKIII gene family. We excluded the possi-
bility that theVKIIIbX14 gene segment was an allelic variant
of kv325 by showing that the germline of patient Tou lacked
the mutated sequence of VKIIIbT14 and indeed contained
an exact copy of the kv325 gene segment. Expression of the
unmutated or mutated kv325 L chain in Ig molecules can
be detected by the monoclonal antiidiotypic antibody JG-B1.
Indeed, T14 supernatant reacted with this mAb in anELISA .
Several reports haveshown that the kv325 gene, expressed
in <1% of peripheral bloodB cells, is preferentially expressed
in ic-bearing CLL cells and small lymphocytic NonHodgkin
lymphoma, both neoplasms that commonly express theCD5
surface antigen (42, 43) . Moreover, this particular VK gene
segment is frequently associated with IgM paraproteins with
autoantibody activity (44, 45) and was found in a multireac-tive IgM anti-DNA/rheumatoid factor autoantibody from
a leprosy patient (17). Further indirect support for a possible
relationship between VKIIIb expression and autoreactivity
in the CD5+ B cell population comes from the notion that
both normal and malignant CD5+ B cells secrete autoanti-
bodies after stimulation in vitro (46, 47) and the clinical ob-
servation that the sera of some patients with CLL contain
autoantibodies and that 20% of these CLL patients develop
autoimmune phenomena (48) . In this context, the expres-
sion of a somatically mutated variant of kv325 in the IgG
anti-DNA autoantibody T14 further suggests that this VK
gene predisposes for autoreactivity, perhaps in combination
with particularVH genes. Whether cell line T14 derived from
a CD5+ B cell could not be established since many EBV-
transformed cell lineslose CD5 expression after transforma-
tion. Indeed, T14 lacked CD5 expression at both the RNA
and protein level.
Somatic Mutations in the T14 VH and VL Regions.
￿
The
VH and VL genesexpressed in the IgG anti-DNA-secreting
cell line T14 differ by 14 and 5 nucleotides from the patients
own germline VH4.21 and VKIIIb counterparts. The nucleo-
tide differences are concentrated in the CDR regions and
mainly lead to amino acid replacements. Such a nonrandom
pattern of replacement mutations is highly suggestive of an
antigen-driven B cell activation and selection process (12).
Strikingly, the replacement mutations in CDR1 and CDR2
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